Tauriga Sciences Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Tauriga Sciences are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tauriga Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tauriga Sciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 5348.00 | |
| Total Cashflows From Investing Activities | -420 K |
Tauriga |
Tauriga Sciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Tauriga Sciences on September 1, 2024 and sell it today you would earn a total of 100.00 from holding Tauriga Sciences or generate -100.0% return on investment over 90 days. Tauriga Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Tauriga, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tauriga Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tauriga Sciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Tauriga Sciences, and traders can use it to determine the average amount a Tauriga Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TAUG |
Based on monthly moving average Tauriga Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tauriga Sciences by adding Tauriga Sciences to a well-diversified portfolio.
Tauriga Sciences Fundamentals Growth
Tauriga OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Tauriga Sciences, and Tauriga Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tauriga OTC Stock performance.
| Return On Equity | -63.19 | |||
| Return On Asset | -1.72 | |||
| Operating Margin | (17.15) % | |||
| Current Valuation | 519.42 K | |||
| Shares Outstanding | 299.91 M | |||
| Price To Earning | 1.82 X | |||
| Price To Book | 6.60 X | |||
| Price To Sales | 0 X | |||
| Revenue | 285.32 K | |||
| EBITDA | (2.53 M) | |||
| Cash And Equivalents | 1.02 M | |||
| Total Debt | 1.51 M | |||
| Debt To Equity | 0.85 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (2.55 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 2.49 M | |||
| Retained Earnings | (53.26 M) | |||
| Current Liabilities | 2.96 M | |||
About Tauriga Sciences Performance
By analyzing Tauriga Sciences' fundamental ratios, stakeholders can gain valuable insights into Tauriga Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tauriga Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tauriga Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York. Tauriga Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Tauriga Sciences performance evaluation
Checking the ongoing alerts about Tauriga Sciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Tauriga Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tauriga Sciences is not yet fully synchronised with the market data | |
| Tauriga Sciences has some characteristics of a very speculative penny stock | |
| Tauriga Sciences has a very high chance of going through financial distress in the upcoming years | |
| Tauriga Sciences currently holds 1.51 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Tauriga Sciences has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Tauriga Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Tauriga Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Tauriga Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Tauriga to invest in growth at high rates of return. When we think about Tauriga Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 285.32 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 122.69 K. | |
| Tauriga Sciences currently holds about 1.02 M in cash with (2.55 M) of positive cash flow from operations. |
- Analyzing Tauriga Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tauriga Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Tauriga Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tauriga Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tauriga Sciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Tauriga Sciences' otc stock. These opinions can provide insight into Tauriga Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Tauriga OTC Stock
If you are still planning to invest in Tauriga Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tauriga Sciences' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |